Switching arms improved effectiveness of two-dose vaccinations, Oregon Health & Science University study suggested
On Feb. 6, 2024, Oregon Health & Science University (OHSU) announced research that revealed as much as a…
New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrated Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster
On Feb. 5, 2024, CSL and and Arcturus Therapeutics announced the results of a follow-up analysis of a…
New study highlighted importance of bird flu surveillance in live bird markets
On Jan. 31, 2024, a U.S. Centers for Disease Control and Prevention (CDC) co-authored study published in Influenza…
HPV vaccine study found zero cases of cervical cancer among women vaccinated before age 14
On Jan. 25, 2024, an historic study out of Scotland showed the real-world impact of vaccines against the…
Beyfortus approved in China for the prevention of RSV disease in infants
On Jan. 4, 2024, AstraZeneca Sanofi’s Beyfortus (nirsevimab), a long-acting monoclonal antibody, was approved in China for the…
CCSL and Arcturus Therapeutics’ ARCT-154 Demonstrated Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster
On Dec. 21, 2023, CSL and and Arcturus Therapeutics announced the results of a Phase 3 study showing…
R21/Matrix-M malaria vaccine granted prequalification by World Health Organization
On Dec. 21, 2023, the World Health Organization (WHO) announced that it had prequalified the R21/Matrix-M malaria vaccine…
COVID-19 vaccinations shifted to regular immunization as COVAX draws to a close
On Dec. 19, 2023, COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020,…
Flu vaccination during pregnancy decreased flu hospitalizations and emergency visits in infants younger than 6 months
On Dec. 18, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced a study that showed…
Novo Nordisk Foundation announced USD $260 million vaccines initiative to fight deadly airborne infections
On Dec. 18, 2023, the Novo Nordisk Foundation announced it was committing up to DKK 1.8 billion (USD…
BioNTech aimed to start mRNA vaccine output in Rwanda in 2025
On Dec. 18, 2023, COVID-19 vaccine maker BioNTech (22UAy.DE) announced that it aims to start production at its…
Novavax’s updated COVID-19 vaccine received Emergency Use Authorization in Taiwan
On Dec. 18, 2023, Novavax announced that the Taiwan Food and Drug Administration had granted emergency use authorization…
CEPI and PATH strengthen partnership to accelerate development of vaccines against diseases with epidemic potential
On Dec. 14, 2023, The Coalition for Epidemic Preparedness Innovations (CEPI) and PATH today announced a renewed collaboration…
Biotechnology | Diagnostics | Disease | Oncology | Vaccine | Women's Health
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
On Dec. 6, 2023, Anixa Biosciences announced updated positive results from the Phase 1 clinical trial of its…
Novavax’s updated COVID-19 vaccine received Emergency Use Authorization in the Republic of Korea
On Dec. 5, 2023, Novavax announced that Health Canada had granted expanded authorization for Nuvaxovid XBB.1.5 Vaccine (Recombinant…
WHO announced influenza A(H1N2) variant virus infection in the Great Britain and Northern Ireland
On Dec. 1, 2023, the World Health Organization (WHO) announced that the International Health Regulations National Focal Point…
WHO announced Avian influenza A (H5N1) cases in Cambodia
On Nov. 29, 2023, the World Health Organization (WHO) announced that between 24 and 25 November 2023, the…
Biotechnology | CDC | Diagnostics | Infectious Disease | Measles | Vaccine
Passenger with measles travelled through Vancouver International Airport
On Nov. 29, 2023, the BC Centre for Disease Controlr Disease Control (BCCDC) announced that a A passenger…
Novavax’s updated COVID-19 vaccine received Emergency Use Authorization in the Republic of Korea
On Nov. 29, 2023, Novavax’s partner, SK bioscience, announced that Novavax’s updated COVID-19 vaccine (NVX-CoV2601) had received Emergency…
Novavax’s updated protein-based COVID-19 vaccine now option for all 194 WHO member states
On Nov. 28, 2023, Novavax announced that Nuvaxovid XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) had been granted Emergency Use Listing…
Emergent received $75 million contract option from BARDA to procure doses of CYFENDUS (Anthrax Vaccine)
On Nov. 28, 2023, Emergent BioSolutions announced that the Biomedical Advanced Research and Development Authority (BARDA) within the…
Japan’s MHLW approved CSL and Arcturus’s self-amplifying mRNA vaccine approved for COVID in adults
On Nov. 28, 2023, CSL and Arcturus Therapeutics announced that Japan’s Ministry of Health, Labor and Welfare (MHLW)…
University of Wisconsin-Madison reported spike in premature births caused by COVID, halted by vaccines
On Nov. 27, 2023, University of Wisconsin-Madison researchers released a study that showed COVID-19 caused an alarming surge…
Biotechnology | Clinical Research | COVID-19 | FDA | Infectious Disease | Medicine | NIH | Therapeutics | Vaccine
FDA issued final guidance on developing drugs for COVID-19 treatment and preventionﾠ
On Nov. 22, 2023, the U.S. Food and Drug Administration (FDA) issued the final guidance COVID-19: Developing Drugs…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
Highly pathogenic Avian influenza spread in Oregon
On Nov. 17, 2023, the Oregon Department of Agriculture has new confirmed cases of avian influenza, and the…
CPRIT invested $63 million to bring innovative researchers and companies to Texas
On Nov. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
CDC published first preliminary in-season flu burden estimates
On Nov. 10, 2023, the Centers for Disease Control and Prevention (CDC) estimated that from October 1, 2023,…
FDA approved first vaccine to prevent disease caused by chikungunya virus
On Nov. 9, 2023, the U.S. Food and Drug Administration (FDA) approved Valneva’s Ixchiq, the first chikungunya vaccine….
Novavax’s updated COVID-19 vaccine approved in the EU
On Oct. 31, 2023, Novavax announced that the European Commission had granted approval for Nuvaxovid XBB.1.5 dispersion for…
Bavarian Nordic’s Mpox vaccine received recommendation from U.S. CDC Advisory Committee for routine use in adults at risk
On Oct. 25, 2023, Bavarian Nordic announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory…